SELLAS Life Sciences Group, Inc. announced the appointment of Gene Mack as Chief Financial Officer and Treasurer. Mr. Mack joins SELLAS having served as a consulting chief financial officer for a number of private and publicly traded biotechnology and pharmaceutical companies, developing strategy and leading management of all company finance, accounting, and treasury functions, most recently with Nicox, SA. Prior to consulting, Mr. Mack held finance and business development positions at Ascendia Pharmaceuticals and Edge Therapeutics.

Interim Chief Financial Officer Aleksey Krylov will remain with SELLAS until July 15th in order to facilitate the transition.